Clinical Cancer Research Versailles No Abst Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ayaki, M.
Right arrow Articles by Nakamura, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ayaki, M.
Right arrow Articles by Nakamura, H.
Clinical Cancer Research Vol. 7, 3106-3112, October 2001
© 2001 American Association for Cancer Research


Regular Articles

Reduced Expression of Focal Adhesion Kinase in Liver Metastases Compared with Matched Primary Human Colorectal Adenocarcinomas1

Masako Ayaki2, Keiko Komatsu, Mutsuko Mukai, Kohei Murata, Masao Kameyama, Shingo Ishiguro, Jun Miyoshi, Masaharu Tatsuta and Hiroyuki Nakamura

Departments of Tumor Biochemistry [M. A., K. K., M. M., H. N.], Surgery [K. M., M. K.], Pathology [S. I.], Molecular Biology [J. M.], and Gastrointestinal Oncology [M. T.], Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537-8511, Japan

The focal adhesion kinase (FAK) is implicated in integrin-mediated signal transduction pathways used in cell adhesion, cell motility, apoptosis, and anchorage-independent growth. Because cancer invasion and metastasis are thought to be associated with alterations in cellular adhesive and motile properties, we studied the expression of four focal adhesion proteins including FAK in matched samples of human normal colorectal mucosa (N), primary colorectal adenocarcinomas (T) and liver metastases (M) from 10 patients by Western blot analysis. This gave us the advantage of directly comparing levels of focal adhesion protein expression within the same genetic background. Average FAK expression level was significantly higher in T than in N and it was significantly lower in M than in T. Average paxillin expression level was also significantly higher in T than in N, but it was not significantly different between T and M. Similar results were obtained by immunohistochemical analyses of FAK and paxillin expression. Average vinculin and talin expression levels showed no significant differences among these three samples (N, T, and M). These data demonstrate that the FAK expression level increases in primary tumors compared with normal mucosa and decreases in liver metastases to the level of normal mucosa in the majority of human colorectal adenocarcinomas. Up- and down-regulation of FAK protein expression observed in this study may have a profound effect on the signal transduction.




This article has been cited by other articles:


Home page
Am Soc Clin Oncol Ed BookHome page
H. K. Gan and L. L. Siu
Focal Adhesion Kinase as a Therapeutic Target in Cancer
ASCO Educational Book, January 1, 2009; 2009(1): 130 - 136.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
D. M. Pirone, W. F. Liu, S. A. Ruiz, L. Gao, S. Raghavan, C. A. Lemmon, L. H. Romer, and C. S. Chen
An inhibitory role for FAK in regulating proliferation: a link between limited adhesion and RhoA-ROCK signaling
J. Cell Biol., July 17, 2006; 174(2): 277 - 288.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Gabriel, A. zur Hausen, E. Stickeler, C. Dietz, G. Gitsch, D.-C. Fischer, J. Bouda, C. Tempfer, and A. Hasenburg
Weak Expression of Focal Adhesion Kinase (pp125FAK) in Patients with Cervical Cancer Is Associated with Poor Disease Outcome
Clin. Cancer Res., April 15, 2006; 12(8): 2476 - 2483.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. K. Sood, J. E. Coffin, G. B. Schneider, M. S. Fletcher, B. R. DeYoung, L. M. Gruman, D. M. Gershenson, M. D. Schaller, and M. J.C. Hendrix
Biological Significance of Focal Adhesion Kinase in Ovarian Cancer: Role in Migration and Invasion
Am. J. Pathol., October 1, 2004; 165(4): 1087 - 1095.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
K. A. Matkowskyj, K. Keller, S. Glover, L. Kornberg, R. Tran-Son-Tay, and R. V. Benya
Expression of GRP and Its Receptor in Well-differentiated Colon Cancer Cells Correlates with the Presence of Focal Adhesion Kinase Phosphorylated at Tyrosines 397 and 407
J. Histochem. Cytochem., August 1, 2003; 51(8): 1041 - 1048.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
V. M. Golubovskaya, S. Gross, A. S. Kaur, R. I. Wilson, L.-H. Xu, X. H. Yang, and W. G. Cance
Simultaneous Inhibition of Focal Adhesion Kinase and Src Enhances Detachment and Apoptosis in Colon Cancer Cell Lines
Mol. Cancer Res., August 1, 2003; 1(10): 755 - 764.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. L. Lark, C. A. Livasy, B. Calvo, L. Caskey, D. T. Moore, X. Yang, and W. G. Cance
Overexpression of Focal Adhesion Kinase in Primary Colorectal Carcinomas and Colorectal Liver Metastases: Immunohistochemistry and Real-Time PCR Analyses
Clin. Cancer Res., January 1, 2003; 9(1): 215 - 222.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.